People: Transition Therapeutics Inc (TTH.TO)
5 Dec 2013
Mr. Paul Baehr is Independent Director of Transition Therapeutics Inc. Mr. Baehr has a B.A. from the University of British Columbia. He is currently President, Chief Executive Officer and Chairman of IBEX Technologies Inc., a biotechnology company listed on the TSX under the symbol “IBT”. Previously, Mr. Baehr was an Executive Vice President at Sterling Winthrop and prior thereto a Senior Vice President at CIBA-GEIGY Pharmaceuticals, both of which are pharmaceutical companies. In addition, Mr. Baehr currently sits on the board of directors of IBEX Technologies Inc., a public company.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|